British American Tobacco p.l.c. BATS.L
GB · London Stock Exchange · XLON · stock · Consumer Defensive · website
British American Tobacco p.l.c. financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $25.6B | $25.9B | $27.3B | $27.7B |
| Gross profit | $21.4B | $21.4B | $22.6B | $23.1B |
| R&D expense | $133.0M | $174.0M | $181.0M | $138.0M |
| SG&A expense | $1.1B | $1.1B | $1.2B | $1.2B |
| Operating income | $11.7B | $10.6B | -$8.5B | $14.3B |
| Interest expense | $1.9B | $1.8B | $1.9B | $1.7B |
| Income tax | $2.1B | $357.0M | -$2.9B | $2.5B |
| Net income | $7.8B | $3.1B | -$14.4B | $6.7B |
| EPS (diluted) | $3.49 | $1.36 | $-6.47 | $2.92 |
| Operating cash flow | $6.3B | $10.1B | $10.7B | $10.4B |
| Free cash flow | $5.6B | $9.5B | $10.1B | $9.7B |
| Cash & equivalents | $3.5B | $2.9B | $2.4B | $1.7B |
| Inventory | $4.4B | $4.6B | $4.9B | $5.7B |
| Total assets | $109.3B | $118.9B | $118.7B | $153.5B |
| Total liabilities | $61.1B | $68.9B | $65.8B | $77.8B |
| Shareholders' equity | $47.9B | $49.6B | $52.6B | $75.4B |
Growth · year-over-year · Revenue CAGR -2.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -1.0% | -5.2% | -1.3% | — |
| Net income growth | +153.1% | — | -315.5% | — |
| EPS growth | +156.7% | — | -321.5% | — |
| Free cash flow growth | -40.8% | -5.9% | +3.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · GB · as of 2025-12-31. Figures in GBp; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.